胎肝造血细胞在造血障碍疾病治疗中的应用

• 作 者: 孟昭峰
• 机 构: 洛阳市第一人民医院,
• 出 处: 临床医学
• 发表日期: 1986年03期
• 关键词: 造血细胞 胎肝细胞 同种骨髓移植 再障 免疫缺陷病 致死量 再生障碍性贫血 障碍疾病 造血功能 祖细胞

近十年来同种骨髓移植已有了相当进展,对先天免疫缺陷病、再生障碍性贫血(再障)及白血病等均取得了较好的疗效.本文重点以治疗再障为例,论述胎肝造血细胞(FHC)临床应用中的几个有关问题.简史早在1853年 Kolliker 就指出胎肝是主动造血部位.1958年 Uphoff 成功地用胚肝治愈了致死量照

In the past ten years, allogeneic bone marrow transplantation has made considerable progress, and has achieved good results in the treatment of congenital immunodeficiency disease, aplastic anemia (aplastic anemia) and leukemia, etc. This article focuses on the treatment of aplastic anemia as an example, discusses the fetal liver Several issues related to clinical application of hematopoietic cells (FHCs) Brief history Kolliker pointed out that fetal liver was the active hematopoietic site as early as 1853. In 1958, Uphoff successfully cured lethal dose with embryonic liver